We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Method for Improved Intraoperative Blood Loss Estimates (EBL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01634828
Recruitment Status : Completed
First Posted : July 6, 2012
Last Update Posted : May 12, 2016
Information provided by (Responsible Party):
Annette Macintyre, University of Utah

Brief Summary:
The purpose of this study is to develop a mathematical algorithm which the investigators plan to use to more accurately estimate intraoperative blood loss.

Condition or disease
Improved Intraoperative Blood Loss Estimates

Study Type : Observational
Actual Enrollment : 47 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Method for Improved Intraoperative Blood Loss Estimates
Study Start Date : July 2012
Primary Completion Date : April 2015
Study Completion Date : April 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding
U.S. FDA Resources

Minimal blood loss patients
Moderate to heavy blood loss patients

Primary Outcome Measures :
  1. Estimate of intraoperative blood loss [ Time Frame: duration of surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elective surgical patients

Inclusion Criteria:

All elective surgical patients

Exclusion Criteria:

  1. Age < 18
  2. Pregnant women
  3. Prisoners
  4. Lack of informed consent
  5. Attending Physician feels enrollment could interfere with optimal patient care
  6. Patients who did not have a preoperative hemoglobin measured as part of their preoperative work-up
  7. Patients whose preoperative hemoglobin fraction is abnormal.
  8. Patients who will likely require an intraoperative blood transfusion.
  9. Patients for whom the intraoperative use of the Cell Saver is anticipated.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01634828

United States, Utah
University of Utah
Salt lake City, Utah, United States, 84132
Sponsors and Collaborators
University of Utah

Responsible Party: Annette Macintyre, Principle Investigator, University of Utah
ClinicalTrials.gov Identifier: NCT01634828     History of Changes
Other Study ID Numbers: FP00002762
56181 ( Registry Identifier: IRB University of Utah )
First Posted: July 6, 2012    Key Record Dates
Last Update Posted: May 12, 2016
Last Verified: May 2016

Additional relevant MeSH terms:
Pathologic Processes